Hualei Bu

604 total citations
24 papers, 354 citations indexed

About

Hualei Bu is a scholar working on Molecular Biology, Reproductive Medicine and Oncology. According to data from OpenAlex, Hualei Bu has authored 24 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Reproductive Medicine and 7 papers in Oncology. Recurrent topics in Hualei Bu's work include Ovarian cancer diagnosis and treatment (8 papers), BRCA gene mutations in cancer (4 papers) and FOXO transcription factor regulation (4 papers). Hualei Bu is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), BRCA gene mutations in cancer (4 papers) and FOXO transcription factor regulation (4 papers). Hualei Bu collaborates with scholars based in China, Germany and Singapore. Hualei Bu's co-authors include Chengjuan Jin, Beihua Kong, Yu Wang, Zhaojian Liu, Yingwei Li, Youzhong Zhang, Hongfeng Yu, Chunping Qiu, Nan Lü and Beihua Kong and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Experimental Cell Research.

In The Last Decade

Hualei Bu

23 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hualei Bu China 11 173 118 102 91 59 24 354
Kristen Bunch United States 8 140 0.8× 101 0.9× 94 0.9× 50 0.5× 40 0.7× 18 311
Moito Iijima Japan 8 152 0.9× 78 0.7× 92 0.9× 81 0.9× 20 0.3× 18 315
Alba Martínez United States 6 121 0.7× 77 0.7× 83 0.8× 112 1.2× 15 0.3× 10 287
Pi‐Lin Sung Taiwan 12 113 0.7× 82 0.7× 109 1.1× 56 0.6× 42 0.7× 16 340
Shuqi Chi China 11 191 1.1× 56 0.5× 95 0.9× 101 1.1× 31 0.5× 19 346
Seden Küçücük Türkiye 11 103 0.6× 131 1.1× 36 0.4× 116 1.3× 41 0.7× 32 322
Areeg Faggad Sudan 12 268 1.5× 96 0.8× 44 0.4× 164 1.8× 31 0.5× 18 406
Julie Irving Canada 6 184 1.1× 91 0.8× 160 1.6× 49 0.5× 35 0.6× 6 359
Nicoletta Provinciali Italy 9 83 0.5× 175 1.5× 54 0.5× 119 1.3× 48 0.8× 22 308
Haruko Kunitomi Japan 9 183 1.1× 71 0.6× 35 0.3× 112 1.2× 23 0.4× 17 311

Countries citing papers authored by Hualei Bu

Since Specialization
Citations

This map shows the geographic impact of Hualei Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hualei Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hualei Bu more than expected).

Fields of papers citing papers by Hualei Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hualei Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hualei Bu. The network helps show where Hualei Bu may publish in the future.

Co-authorship network of co-authors of Hualei Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Hualei Bu. A scholar is included among the top collaborators of Hualei Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hualei Bu. Hualei Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Jianqing, Guangyi Jiang, Jie Tang, et al.. (2025). SHR-2004, A Novel Humanised Monoclonal Antibody Targeting Factor XI (FXI), For Preventing Venous Thromboembolism (VTE) In Patients Undergoing Surgery For Ovarian Cancer: A Randomised, Active-Control Phase 2 Study. International Journal of Gynecological Cancer. 35(2). 101706–101706. 1 indexed citations
2.
3.
Zhang, Jian, Rujiao Liu, Shuiping Gao, et al.. (2024). 9MW2821, a nectin-4 antibody-drug conjugate (ADC), in patients with advanced solid tumor: Results from a phase 1/2a study.. Journal of Clinical Oncology. 42(16_suppl). 3013–3013. 6 indexed citations
4.
Bu, Hualei, Yuanjian Wang, Ran Chu, et al.. (2024). Association between coffee and tea consumption and ovarian cancer incidence: A prospective analysis in the PLCO dataset. International Journal of Cancer. 155(6). 1033–1044. 2 indexed citations
5.
Bu, Hualei, Zhaoyang Zhang, Ran Chu, et al.. (2023). Clinical features and prognostic factors analysis of intravenous leiomyomatosis. Frontiers in Surgery. 9. 1020004–1020004. 8 indexed citations
6.
Bu, Hualei, et al.. (2022). Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy. Journal of Oncology. 2022. 1–15. 27 indexed citations
7.
Bu, Hualei, et al.. (2022). Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer. Frontiers in Oncology. 12. 861392–861392. 5 indexed citations
8.
Jin, Chengjuan, Shuai Feng, Yang Zhang, et al.. (2022). Effects of Neoadjuvant Chemotherapy in Ovarian Cancer Patients With Different Germline BRCA1/2 Mutational Status: A Retrospective Cohort Study. Frontiers in Oncology. 11. 810099–810099. 2 indexed citations
9.
Bu, Hualei, Yan Fang, Chunling Wang, et al.. (2021). Parallel Loop Binding Compression Suture, a Modified Procedure for Pernicious Placenta Previa Complicated With Placenta Increta. Frontiers in Surgery. 8. 786497–786497. 5 indexed citations
10.
Peng, Jin, Min Liu, Xi Zhang, et al.. (2021). Enhanced Recovery After Surgery Impact on the Systemic Inflammatory Response of Patients Following Gynecological Oncology Surgery: A Prospective Randomized Study. Cancer Management and Research. Volume 13. 4383–4392. 15 indexed citations
11.
Meng, Jinyu, Jin Peng, Jie Feng, et al.. (2021). Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer. Journal of Translational Medicine. 19(1). 415–415. 38 indexed citations
12.
Pu, Yingying, et al.. (2020). Severe hyponatremia in preeclampsia: a case report and review of the literature. Archives of Gynecology and Obstetrics. 303(4). 925–931. 4 indexed citations
13.
14.
Bu, Hualei, Yingwei Li, Chengjuan Jin, et al.. (2020). Overexpression of PRC1 indicates a poor prognosis in ovarian cancer. International Journal of Oncology. 56(3). 685–696. 25 indexed citations
15.
Li, Yingwei, Haiyang Guo, Zixiang Wang, et al.. (2020). Cyclin F and KIF20A, FOXM1 target genes, increase proliferation and invasion of ovarian cancer cells. Experimental Cell Research. 395(2). 112212–112212. 31 indexed citations
16.
17.
Jin, Chengjuan, Zhaojian Liu, Yingwei Li, et al.. (2018). PCNA‐associated factor P15PAF, targeted by FOXM1, predicts poor prognosis in high‐grade serous ovarian cancer patients. International Journal of Cancer. 143(11). 2973–2984. 29 indexed citations
18.
Qiu, Chunping, Yu Wang, Xiao Wang, et al.. (2018). Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma. International Journal of Oncology. 52(6). 2041–2050. 3 indexed citations
19.
Wu, Xiaohua, Lingying Wu, Beihua Kong, et al.. (2017). The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients. International Journal of Gynecological Cancer. 27(8). 1650–1657. 55 indexed citations
20.
Jin, Chengjuan, et al.. (2015). Coexistence of benign struma ovarii, pseudo-Meigs’ syndrome and elevated serum CA 125: Case report and review of the literature. Oncology Letters. 9(4). 1739–1742. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristen Bunch Breakdown of academic impact, for papers by Moito Iijima Breakdown of academic impact, for papers by Alba Martínez Breakdown of academic impact, for papers by Pi‐Lin Sung Breakdown of academic impact, for papers by Shuqi Chi Breakdown of academic impact, for papers by Seden Küçücük Breakdown of academic impact, for papers by Areeg Faggad Breakdown of academic impact, for papers by Julie Irving Breakdown of academic impact, for papers by Nicoletta Provinciali Breakdown of academic impact, for papers by Haruko Kunitomi
Rankless by CCL
2026